Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Biomarkers Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Enzyme Linked Immunosorbent Assay (ELISA)
1.2.3 Enzymatic Assay
1.2.4 Turbidimetric Immunoassay
1.2.5 Others
1.3 Market by Application
1.3.1 Global Renal Biomarkers Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Diagnosis and Disease Progression Monitoring
1.3.3 Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Biomarkers Market Perspective (2018-2033)
2.2 Renal Biomarkers Growth Trends by Region
2.2.1 Global Renal Biomarkers Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Renal Biomarkers Historic Market Size by Region (2018-2023)
2.2.3 Renal Biomarkers Forecasted Market Size by Region (2024-2033)
2.3 Renal Biomarkers Market Dynamics
2.3.1 Renal Biomarkers Industry Trends
2.3.2 Renal Biomarkers Market Drivers
2.3.3 Renal Biomarkers Market Challenges
2.3.4 Renal Biomarkers Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Biomarkers Players by Revenue
3.1.1 Global Top Renal Biomarkers Players by Revenue (2018-2023)
3.1.2 Global Renal Biomarkers Revenue Market Share by Players (2018-2023)
3.2 Global Renal Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Renal Biomarkers Revenue
3.4 Global Renal Biomarkers Market Concentration Ratio
3.4.1 Global Renal Biomarkers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Biomarkers Revenue in 2022
3.5 Renal Biomarkers Key Players Head office and Area Served
3.6 Key Players Renal Biomarkers Product Solution and Service
3.7 Date of Enter into Renal Biomarkers Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Biomarkers Breakdown Data by Type
4.1 Global Renal Biomarkers Historic Market Size by Type (2018-2023)
4.2 Global Renal Biomarkers Forecasted Market Size by Type (2024-2033)
5 Renal Biomarkers Breakdown Data by Application
5.1 Global Renal Biomarkers Historic Market Size by Application (2018-2023)
5.2 Global Renal Biomarkers Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Renal Biomarkers Market Size (2018-2033)
6.2 North America Renal Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Renal Biomarkers Market Size by Country (2018-2023)
6.4 North America Renal Biomarkers Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Biomarkers Market Size (2018-2033)
7.2 Europe Renal Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Renal Biomarkers Market Size by Country (2018-2023)
7.4 Europe Renal Biomarkers Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Biomarkers Market Size (2018-2033)
8.2 Asia-Pacific Renal Biomarkers Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Renal Biomarkers Market Size by Region (2018-2023)
8.4 Asia-Pacific Renal Biomarkers Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Biomarkers Market Size (2018-2033)
9.2 Latin America Renal Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Renal Biomarkers Market Size by Country (2018-2023)
9.4 Latin America Renal Biomarkers Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Biomarkers Market Size (2018-2033)
10.2 Middle East & Africa Renal Biomarkers Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Renal Biomarkers Market Size by Country (2018-2023)
10.4 Middle East & Africa Renal Biomarkers Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Diagnostics
11.1.1 Abbott Diagnostics Company Detail
11.1.2 Abbott Diagnostics Business Overview
11.1.3 Abbott Diagnostics Renal Biomarkers Introduction
11.1.4 Abbott Diagnostics Revenue in Renal Biomarkers Business (2018-2023)
11.1.5 Abbott Diagnostics Recent Development
11.2 F. Hoffmann-La Roche
11.2.1 F. Hoffmann-La Roche Company Detail
11.2.2 F. Hoffmann-La Roche Business Overview
11.2.3 F. Hoffmann-La Roche Renal Biomarkers Introduction
11.2.4 F. Hoffmann-La Roche Revenue in Renal Biomarkers Business (2018-2023)
11.2.5 F. Hoffmann-La Roche Recent Development
11.3 Beckman Coulter
11.3.1 Beckman Coulter Company Detail
11.3.2 Beckman Coulter Business Overview
11.3.3 Beckman Coulter Renal Biomarkers Introduction
11.3.4 Beckman Coulter Revenue in Renal Biomarkers Business (2018-2023)
11.3.5 Beckman Coulter Recent Development
11.4 Siemens Healthcare Diagnostics
11.4.1 Siemens Healthcare Diagnostics Company Detail
11.4.2 Siemens Healthcare Diagnostics Business Overview
11.4.3 Siemens Healthcare Diagnostics Renal Biomarkers Introduction
11.4.4 Siemens Healthcare Diagnostics Revenue in Renal Biomarkers Business (2018-2023)
11.4.5 Siemens Healthcare Diagnostics Recent Development
11.5 Thermo Fisher Scientific
11.5.1 Thermo Fisher Scientific Company Detail
11.5.2 Thermo Fisher Scientific Business Overview
11.5.3 Thermo Fisher Scientific Renal Biomarkers Introduction
11.5.4 Thermo Fisher Scientific Revenue in Renal Biomarkers Business (2018-2023)
11.5.5 Thermo Fisher Scientific Recent Development
11.6 Astute Medical
11.6.1 Astute Medical Company Detail
11.6.2 Astute Medical Business Overview
11.6.3 Astute Medical Renal Biomarkers Introduction
11.6.4 Astute Medical Revenue in Renal Biomarkers Business (2018-2023)
11.6.5 Astute Medical Recent Development
11.7 BioMerieux SA
11.7.1 BioMerieux SA Company Detail
11.7.2 BioMerieux SA Business Overview
11.7.3 BioMerieux SA Renal Biomarkers Introduction
11.7.4 BioMerieux SA Revenue in Renal Biomarkers Business (2018-2023)
11.7.5 BioMerieux SA Recent Development
11.8 Randox Laboratories
11.8.1 Randox Laboratories Company Detail
11.8.2 Randox Laboratories Business Overview
11.8.3 Randox Laboratories Renal Biomarkers Introduction
11.8.4 Randox Laboratories Revenue in Renal Biomarkers Business (2018-2023)
11.8.5 Randox Laboratories Recent Development
11.9 Diagnostics A/S
11.9.1 Diagnostics A/S Company Detail
11.9.2 Diagnostics A/S Business Overview
11.9.3 Diagnostics A/S Renal Biomarkers Introduction
11.9.4 Diagnostics A/S Revenue in Renal Biomarkers Business (2018-2023)
11.9.5 Diagnostics A/S Recent Development
11.10 Sphingo Tec GmbH
11.10.1 Sphingo Tec GmbH Company Detail
11.10.2 Sphingo Tec GmbH Business Overview
11.10.3 Sphingo Tec GmbH Renal Biomarkers Introduction
11.10.4 Sphingo Tec GmbH Revenue in Renal Biomarkers Business (2018-2023)
11.10.5 Sphingo Tec GmbH Recent Development
11.11 Eli Lilly and Company
11.11.1 Eli Lilly and Company Company Detail
11.11.2 Eli Lilly and Company Business Overview
11.11.3 Eli Lilly and Company Renal Biomarkers Introduction
11.11.4 Eli Lilly and Company Revenue in Renal Biomarkers Business (2018-2023)
11.11.5 Eli Lilly and Company Recent Development
11.12 Novartis AG
11.12.1 Novartis AG Company Detail
11.12.2 Novartis AG Business Overview
11.12.3 Novartis AG Renal Biomarkers Introduction
11.12.4 Novartis AG Revenue in Renal Biomarkers Business (2018-2023)
11.12.5 Novartis AG Recent Development
11.13 Gentian Diagnostic
11.13.1 Gentian Diagnostic Company Detail
11.13.2 Gentian Diagnostic Business Overview
11.13.3 Gentian Diagnostic Renal Biomarkers Introduction
11.13.4 Gentian Diagnostic Revenue in Renal Biomarkers Business (2018-2023)
11.13.5 Gentian Diagnostic Recent Development
11.14 Proteomics International
11.14.1 Proteomics International Company Detail
11.14.2 Proteomics International Business Overview
11.14.3 Proteomics International Renal Biomarkers Introduction
11.14.4 Proteomics International Revenue in Renal Biomarkers Business (2018-2023)
11.14.5 Proteomics International Recent Development
11.15 BioPorto
11.15.1 BioPorto Company Detail
11.15.2 BioPorto Business Overview
11.15.3 BioPorto Renal Biomarkers Introduction
11.15.4 BioPorto Revenue in Renal Biomarkers Business (2018-2023)
11.15.5 BioPorto Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Renal Biomarkers Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Enzyme Linked Immunosorbent Assay (ELISA)
Table 3. Key Players of Enzymatic Assay
Table 4. Key Players of Turbidimetric Immunoassay
Table 5. Key Players of Others
Table 6. Global Renal Biomarkers Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Renal Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Renal Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Renal Biomarkers Market Share by Region (2018-2023)
Table 10. Global Renal Biomarkers Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Renal Biomarkers Market Share by Region (2024-2033)
Table 12. Renal Biomarkers Market Trends
Table 13. Renal Biomarkers Market Drivers
Table 14. Renal Biomarkers Market Challenges
Table 15. Renal Biomarkers Market Restraints
Table 16. Global Renal Biomarkers Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Renal Biomarkers Market Share by Players (2018-2023)
Table 18. Global Top Renal Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2022)
Table 19. Ranking of Global Top Renal Biomarkers Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Renal Biomarkers Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Renal Biomarkers Product Solution and Service
Table 23. Date of Enter into Renal Biomarkers Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Renal Biomarkers Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Renal Biomarkers Revenue Market Share by Type (2018-2023)
Table 27. Global Renal Biomarkers Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Renal Biomarkers Revenue Market Share by Type (2024-2033)
Table 29. Global Renal Biomarkers Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Renal Biomarkers Revenue Market Share by Application (2018-2023)
Table 31. Global Renal Biomarkers Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Renal Biomarkers Revenue Market Share by Application (2024-2033)
Table 33. North America Renal Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Renal Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Renal Biomarkers Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Renal Biomarkers Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Renal Biomarkers Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Renal Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Renal Biomarkers Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Renal Biomarkers Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Renal Biomarkers Market Size by Country (2024-2033) & (US$ Million)
Table 48. Abbott Diagnostics Company Detail
Table 49. Abbott Diagnostics Business Overview
Table 50. Abbott Diagnostics Renal Biomarkers Product
Table 51. Abbott Diagnostics Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 52. Abbott Diagnostics Recent Development
Table 53. F. Hoffmann-La Roche Company Detail
Table 54. F. Hoffmann-La Roche Business Overview
Table 55. F. Hoffmann-La Roche Renal Biomarkers Product
Table 56. F. Hoffmann-La Roche Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 57. F. Hoffmann-La Roche Recent Development
Table 58. Beckman Coulter Company Detail
Table 59. Beckman Coulter Business Overview
Table 60. Beckman Coulter Renal Biomarkers Product
Table 61. Beckman Coulter Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 62. Beckman Coulter Recent Development
Table 63. Siemens Healthcare Diagnostics Company Detail
Table 64. Siemens Healthcare Diagnostics Business Overview
Table 65. Siemens Healthcare Diagnostics Renal Biomarkers Product
Table 66. Siemens Healthcare Diagnostics Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 67. Siemens Healthcare Diagnostics Recent Development
Table 68. Thermo Fisher Scientific Company Detail
Table 69. Thermo Fisher Scientific Business Overview
Table 70. Thermo Fisher Scientific Renal Biomarkers Product
Table 71. Thermo Fisher Scientific Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 72. Thermo Fisher Scientific Recent Development
Table 73. Astute Medical Company Detail
Table 74. Astute Medical Business Overview
Table 75. Astute Medical Renal Biomarkers Product
Table 76. Astute Medical Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 77. Astute Medical Recent Development
Table 78. BioMerieux SA Company Detail
Table 79. BioMerieux SA Business Overview
Table 80. BioMerieux SA Renal Biomarkers Product
Table 81. BioMerieux SA Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 82. BioMerieux SA Recent Development
Table 83. Randox Laboratories Company Detail
Table 84. Randox Laboratories Business Overview
Table 85. Randox Laboratories Renal Biomarkers Product
Table 86. Randox Laboratories Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 87. Randox Laboratories Recent Development
Table 88. Diagnostics A/S Company Detail
Table 89. Diagnostics A/S Business Overview
Table 90. Diagnostics A/S Renal Biomarkers Product
Table 91. Diagnostics A/S Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 92. Diagnostics A/S Recent Development
Table 93. Sphingo Tec GmbH Company Detail
Table 94. Sphingo Tec GmbH Business Overview
Table 95. Sphingo Tec GmbH Renal Biomarkers Product
Table 96. Sphingo Tec GmbH Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 97. Sphingo Tec GmbH Recent Development
Table 98. Eli Lilly and Company Company Detail
Table 99. Eli Lilly and Company Business Overview
Table 100. Eli Lilly and Company Renal Biomarkers Product
Table 101. Eli Lilly and Company Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 102. Eli Lilly and Company Recent Development
Table 103. Novartis AG Company Detail
Table 104. Novartis AG Business Overview
Table 105. Novartis AG Renal Biomarkers Product
Table 106. Novartis AG Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 107. Novartis AG Recent Development
Table 108. Gentian Diagnostic Company Detail
Table 109. Gentian Diagnostic Business Overview
Table 110. Gentian Diagnostic Renal Biomarkers Product
Table 111. Gentian Diagnostic Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 112. Gentian Diagnostic Recent Development
Table 113. Proteomics International Company Detail
Table 114. Proteomics International Business Overview
Table 115. Proteomics International Renal Biomarkers Product
Table 116. Proteomics International Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 117. Proteomics International Recent Development
Table 118. BioPorto Company Detail
Table 119. BioPorto Business Overview
Table 120. BioPorto Renal Biomarkers Product
Table 121. BioPorto Revenue in Renal Biomarkers Business (2018-2023) & (US$ Million)
Table 122. BioPorto Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Renal Biomarkers Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Renal Biomarkers Market Share by Type: 2022 VS 2033
Figure 3. Enzyme Linked Immunosorbent Assay (ELISA) Features
Figure 4. Enzymatic Assay Features
Figure 5. Turbidimetric Immunoassay Features
Figure 6. Others Features
Figure 7. Global Renal Biomarkers Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Renal Biomarkers Market Share by Application: 2022 VS 2033
Figure 9. Diagnosis and Disease Progression Monitoring Case Studies
Figure 10. Research Case Studies
Figure 11. Others Case Studies
Figure 12. Renal Biomarkers Report Years Considered
Figure 13. Global Renal Biomarkers Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Renal Biomarkers Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Renal Biomarkers Market Share by Region: 2022 VS 2033
Figure 16. Global Renal Biomarkers Market Share by Players in 2022
Figure 17. Global Top Renal Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Biomarkers as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Renal Biomarkers Revenue in 2022
Figure 19. North America Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Renal Biomarkers Market Share by Country (2018-2033)
Figure 21. United States Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Renal Biomarkers Market Share by Country (2018-2033)
Figure 25. Germany Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Renal Biomarkers Market Share by Region (2018-2033)
Figure 33. China Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Renal Biomarkers Market Share by Country (2018-2033)
Figure 41. Mexico Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Renal Biomarkers Market Share by Country (2018-2033)
Figure 45. Turkey Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Renal Biomarkers Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Abbott Diagnostics Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 48. F. Hoffmann-La Roche Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 49. Beckman Coulter Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 50. Siemens Healthcare Diagnostics Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 52. Astute Medical Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 53. BioMerieux SA Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 54. Randox Laboratories Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 55. Diagnostics A/S Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 56. Sphingo Tec GmbH Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 57. Eli Lilly and Company Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 58. Novartis AG Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 59. Gentian Diagnostic Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 60. Proteomics International Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 61. BioPorto Revenue Growth Rate in Renal Biomarkers Business (2018-2023)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed